Articles

Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy

Department of Pharmacology, University of Bologna, Bologna, Italy
Department of Haematology/Oncology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
Department of Pharmacology, University of Bologna, Bologna, Italy
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Department of Pharmacology, University of Bologna, Bologna, Italy
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Haematology Unit and Department of Biochemistry and Medical Biotechnology, CEINGE-Advanced Biotechnology, University of Naples “Federico II”, Naples, Italy
Department of Haematology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia
Department of Haematology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
The Catholic University of Korea, Seoul St Mary's Hospital, Seoul, South Korea
Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
Department of Haematology/Oncology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
Department of Biology, University of Bologna, Bologna, Italy
Novartis Oncology, Florham Park, NJ, USA
Department of Pharmacology, University of Bologna, Bologna, Italy
Department of Haematology/Oncology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
Department of Pharmacology, University of Bologna, Bologna, Italy
Department of Haematology/Oncology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
Vol. 98 No. 2 (2013): February, 2013 https://doi.org/10.3324/haematol.2012.066480